PHYTOMEDICINE SCIE

中文简介

植物医学主要是以治疗为导向的期刊。植物医学发表关于特定植物提取物、植物药物及其分离成分的功效、安全性、质量和作用机制的创新研究。这包括临床、药理学、药代动力学和对特定草药产品、草药制剂和纯化化合物的毒理学研究，这些产品具有明确和一致的质量，保证了可重现的药理活性。植物医学成立于1994年，旨在关注和促进这一特定领域的研究，并为植物医学的药理研究、临床疗效证明和安全性制定国际公认的科学标准。植物医学的主要目的是将植物修复纳入常规/官方医学。该杂志包括以下各部分:临床药理学和毒理学(随机、安慰剂对照、双盲和观察性开放标签研究)行为、心理、情感和压力相关障碍与年龄有关的疾病神经药理学内分泌药理学代谢综合症与肥胖癌症免疫药理学、炎症传染病肺、胃肠、心血管和泌尿生殖系统疾病系统生物学安全性评估，临床前毒理学，与药物的相互作用和草药制剂的不良事件天然化合物的药动学中药制剂标准化立法的植物邀请评审

投稿网址：http://ees.elsevier.com/phymed/

英文简介

Phytomedicine is primarily a therapy-oriented Journal. Phytomedicine publishes innovative studies on efficacy, safety, quality and mechanisms of action of specified plant extracts, phytopharmaceuticals and their isolated constituents. This includes clinical, pharmacological, pharmacokinetic, and toxicological studies of specified herbal medicinal products, herbal preparations and purified compounds which have a defined and consistent quality assuring reproducible pharmacological activity. Phytomedicine was founded in 1994 to focus and stimulate research in this particular field and to set internationally accepted scientific standards for pharmacological studies, proof of clinical efficacy and safety of phytomedicines. ?The main aims of Phytomedicine are associated with the integration of phytopreparations into conventional/official medicine. The journal covers the following sections:Clinical pharmacology and toxicology (randomized, placebo controlled, double blind, and observational open label studies)Behavioural, mental, affective, and stress-associated disordersAge-associated disordersNeuropharmacologyEndocrine pharmacologyMetabolic syndrome and obesityCancerImmunopharmacology, inflammationInfectious diseasesPulmonary, gastrointestinal, cardiovascular and urogenital diseasesSystems biologySafety assessment, pre-clinical toxicology, interaction with drugs and adverse events of herbal preparationsPharmacokinetic of natural compoundsStandardization of herbal preparationsLegislation of botanicalsInvited reviews